News Overview

Bharat Electronics Limited has informed the Exchange regarding a press release dated January 27, 2022, titled BEL signs USD 73 Million contract with Hyperion Global Group LLC, USA, for supply of IoT devices to the US.

TATA CONSUMER PRODUCTS LIMITED has informed the Exchange about Loss of Share Certificates

The Phoenix Mills Limited has informed the Exchange regarding a press release titled The Phoenix Mills Ltd. to generate 5 MW of solar power in collaboration with Renew Power, further strengthening company s sustainability drive.

Laxmi Organic Industries Limited has informed the Exchange about Schedule of meet

K.P.R. Mill Limited has informed the Exchange regarding Disclosure under regulation 7(1)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

Tata Consultancy Services Limited has informed the Exchange regarding a press release dated January 27, 2022, titled TCS Ranked Among Top 2 IoT Service Providers by HFS Research.

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2022, titled Glenmark Pharmaceuticals receives ANDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg.

RBL Bank Limited has informed the Exchange regarding Allotment of 49395 Shares.

Tube Investments of India Limited has informed the Exchange regarding Notice of Postal Ballot relating to Acquisition of controlling interest in M/s. Cellestial E-Mobility Private Limited and related matters Notice of Postal Ballot & E-Voting to Shareholders

Beta Drugs Limited with respect to announcement dated 20-Jan-2022, regarding appointment of Mr. Ashutosh Shukla as Additional Director of the company. On basis of above the company was required to clarify following - 1. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.? The response of the Company is attached.